Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.4843
-0.0537 (-9.98%)
At close: Apr 1, 2025, 4:00 PM
0.4809
-0.0034 (-0.70%)
After-hours: Apr 1, 2025, 6:34 PM EDT

Lyell Immunopharma Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Lyell Immunopharma stock have an average target of 1.00, which predicts an increase of 106.48% from the current stock price of 0.48.

Analyst Consensus: Sell
Target Low Average Median High
Price $1.00 $1.00 $1.00 $1.00
Change +106.48% +106.48% +106.48% +106.48%

Analyst Ratings

The average analyst rating for Lyell Immunopharma stock from 2 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 000000
Buy 000000
Hold 111111
Sell 111111
Strong Sell 000000
Total 222222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$1
Hold Reiterates $1 +106.48% Mar 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$1
Hold Reiterates $1 +106.48% Nov 12, 2024
B of A Securities
B of A Securities
Sell
Downgrades
$6$1
Sell Downgrades $6$1 +106.48% Oct 30, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$1
Hold Reiterates $1 +106.48% Oct 28, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Reiterates
$1
Hold Reiterates $1 +106.48% Aug 19, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 61.00K
Revenue Next Year
66.30K
EPS This Year
-0.76
from -1.31
EPS Next Year
-0.73
from -0.76
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
7.76M10.65M84.68M130.00K61.00K-66.30K-
Revenue Growth
1,080.52%37.31%695.15%-99.85%-53.08%---
EPS
-15.69-1.84-0.74-0.93-1.31-0.76-0.73-0.65
EPS Growth
--------
Forward PE
--------
No. Analysts -----754
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026
High n/a136,500
Avg n/a66,300
Low n/an/a

Revenue Growth

Revenue Growth 20252026
High --
Avg --
Low --

EPS Forecast

EPS 202520262027
High -0.74-0.60-0.42
Avg -0.76-0.73-0.65
Low -0.79-0.84-0.86

EPS Growth

EPS Growth 202520262027
High ---
Avg ---
Low ---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.